Summary
Overview
Work History
Education
Skills
Certification
Languages
Dob
Personal Information
Publications
Timeline
Generic

Moemen Abdalla

St. Catharines

Summary

Dynamic and results-oriented professional with over a decade of experience in sales, marketing, laboratory management, and research within the biotechnology and life sciences sectors. As the Director of Sales and Marketing, adeptly led a 30-member team to drive unprecedented sales growth exceeding $100M during the pandemic, strategically acquiring high-value customers and expanding market share. Concurrently, as the Clinical Laboratory Director, directed regulatory compliance efforts and spearheaded the establishment of Norgen's COVID-19 testing service, ensuring adherence to stringent standards and protocols. With a proven track record of developing and commercializing over 100 products and securing regulatory approvals, possesses a unique blend of scientific expertise and business acumen. Effective in fostering cross-functional collaboration, mentoring teams, and optimizing operational processes to achieve organizational objectives. A strategic thinker with a passion for innovation and a commitment to delivering high-quality solutions in alignment with industry best practices.

Overview

15
15
years of professional experience
1
1
Certification

Work History

Senior Lead Research Scientist

Norgen Biotek Corp
Thorold
01.2010 - 08.2023
  • Developed over 100 products adhering to ISO 13485 standards for DNA/RNA/Protein/Exosome/Virus collection, preservation, and purification from diverse sample types like blood, plasma, serum, urine, and stool
  • Managed multiple contract R&D and clinical trials for esteemed institutes including Brainstorm, FDA, Harvard University, Roswell Park, and Mount Sinai
  • Led regulatory efforts securing CE-Marking and Health Canada approval for more than 50 products
  • Oversaw research, development, and production operations while integrating diverse information sources into actionable reports
  • Created experiment protocols based on scientific principles and authored technical papers and reports
  • Identified areas for process improvement and implemented quality assurance measures
  • Provided mentorship to junior researchers and authored manuscripts for peer-reviewed journals
  • Ensured laboratory compliance with safety regulations and maintained meticulous records
  • Presented research findings at meetings, conferences, and symposia
  • Participated in grant proposal writing and stayed updated on field developments through literature review
  • Led a team to develop new technologies and protocols and identified disease progression biomarkers via genomic analysis.

Clinical Laboratory Director

Norgen Biotek Corp
Thorold
06.2020 - 08.2023
  • Recruited, trained, and supervised laboratory staff, ensuring adherence to proper techniques and safety protocols
  • Led the regulatory team in implementing Norgen's asymptomatic saliva-based COVID-19 testing service following Ontario Ministry of Health License & ISO 15189 certification (OLA Accredited Laboratory)
  • Directed a team of scientists and technicians in establishing the workflow for Norgen's saliva-based COVID-19 testing service
  • Managed the submission of all regulatory documents required for compliance
  • Developed and maintained laboratory protocols, policies, and procedures to ensure safety regulations compliance
  • Implemented innovative strategies to enhance laboratory efficiency
  • Organized and managed workflow for a team of over 10 technicians and scientists
  • Provided direction in designing, developing, and implementing new laboratory processes
  • Conducted research studies, analyzed data, and presented results to senior leadership teams
  • Performed technical troubleshooting on lab equipment as necessary to maintain operational efficiency
  • Ensured accurate record-keeping practices to comply with applicable laws
  • Facilitated interdisciplinary collaboration among scientists to ensure project success.

Director of Sales and Marketing

Norgen Biotek Corp
Thorold
09.2019 - 08.2023
  • Directed and managed a 30-member sales and marketing team handling diverse product portfolios in molecular Sample Collection and Preservation, Purification, and Detection of Nucleic Acids (RNA/DNA)
  • Successfully drove sales growth exceeding $100M during the pandemic for molecular medical devices and nucleic acid purification products
  • Orchestrated the acquisition of high-value customers, generating revenue of $10M+ during the COVID-19 pandemic for FDA-EUA or Health Canada authorized assays
  • Monitored industry trends and competitive landscape to devise effective strategies for enhancing market share
  • Provided strategic direction for digital marketing initiatives including SEO, SEM, email campaigns, and social media platforms
  • Developed a comprehensive plan for tracking key performance indicators related to sales and e-marketing activities
  • Optimized existing processes and developed new initiatives to drive revenue growth and customer loyalty
  • Actively monitored customer feedback to identify areas for product and service improvement
  • Implemented remarketing tactics to target previous visitors with relevant ads across the web
  • Recommended modifications to products, packaging, and production processes to improve environmental sustainability
  • Negotiated contracts with vendors and distributors to manage product distribution and establish global networks
  • Led the organization of trade shows, industry events, and promotional activities to generate leads
  • Evaluated current sales channels and explored new avenues for growth
  • Directed successful marketing campaigns that increased brand awareness and customer loyalty
  • Led the design of creative materials including brochures, flyers, banners, and websites
  • Established processes for lead generation, customer onboarding, and retention programs
  • Developed and maintained relationships with key clients to drive sales
  • Coordinated with internal departments to align sales targets with operational budgets
  • Directed budgeting processes related to advertising campaigns across all channels
  • Established comprehensive training modules for new hires on company policies and procedures
  • Designed and implemented targeted marketing strategies to drive sales
  • Prepared presentations highlighting industry trends related to products and services
  • Monitored inventory to prevent losses and adjusted as needed
  • Led team meetings to discuss best practices in sales and marketing processes
  • Developed effective pricing strategies for over 150 products
  • Resolved customer complaints regarding sales and service
  • Planned and directed staffing, training, and performance evaluations to develop sales and service programs
  • Provided guidance and mentorship to junior-level staff members
  • Determined price schedules and discount rates
  • Represented the company at trade association meetings to promote products
  • Managed relationships with several OEM partners, including Sigma Aldrich, Thermo Fisher, Lexogen, and IZON
  • Performed all duties as a Senior Lead Research Scientist.

Postdoctoral Research Scientist

Norgen Biotek Corp
Thorold
01.2009 - 12.2009

Education

Doctor of Philosophy (Ph.D.) in Biotechnology -

Brock University
St. Catharines, ON
01.2009

Master of Science in Biochemistry -

Alexandria University
Alexandria, EG
08.2001

Bachelor of Science in Biochemistry -

Alexandria University
Alexandria, EG
06.1998

Skills

  • Strategic planning and implementation
  • Project management
  • Leadership and team management
  • Recruitment and Team Development
  • Compliance with regulations and standards
  • Problem-Solving Proficiency
  • Contract negotiation and management
  • Good Laboratory Practice (GLP)
  • Good Manufacturing Practice (GMP)
  • Research study design and publication
  • Laboratory management and safety
  • Stakeholder relationship management
  • Process improvement and innovation
  • Organizational Goal Development

Certification

  • WHMIS: Occupational Health and Safety
  • Implementing ISO 13485:2003
  • MiSeq Training provided by Illumina, Inc.
  • Member of Egyptian Clinical Chemistry Society
  • Dale Carnegie Course: Effective Communication & Human Relations
  • Dale Carnegie Course: Leadership Training for Managers

Languages

English
Arabic

Dob

10/11/76

Personal Information

  • Citizenship: Canadian
  • Gender: Male
  • Marital Status: Married

Publications

  • 13th International Symposium on Molecular Biology of Hematopoiesis (New York, USA, July 14-18, 2000)
  • 1st International Symposium on Heme Oxygenase (New York, USA, July 14- 17, 2000)
  • Molecular Biology Workshop of III International Congress of the African Societies of Biochemistry & Molecular Biology (FASBMB), Cairo, Egypt, Nov. 11-13, 2000.
  • 2nd International Congress of the African Societies of Biochemistry & Molecular Biology (FASBMB), Cairo, Egypt, Nov. 14-16, 2000.
  • 2nd International Conference on Heme Oxygenase (HO/CO) and Cellular Stress Response (Catania – Italy , 2002)
  • 50th Scientific Congress “International Meeting” of the Egyptian Society of Clinical Chemistry, Cairo, Egypt, December 17-19, 2002. Laboratory and Genomic Medicine
  • BioVision Alexandria Conference, Alexandria, Egypt, April 3-7, 2004
  • Bassiouny, AR, Al-Demerdash, M, Kandeel, K, and El Shazly, MS. Th1/Th2 cytokine profile and transforming growth factor beta predict Liver damage in chronic hepatitis C Egyptian patients. Abstract # 9581, FASEB Meeting, Washington, DC April 17-21, 2004.
  • M. Abdalla, Y. Haj-Ahmad. Urinary proteomic and Genomic profile from Hepatitis C virus, Hepatitis B virus and hepatocellular carcinoma patients. HUPO 5th Annual World Congress (October 28 - November 1, 2006, Long Beach, CA, USA).
  • M. Abdalla, Y. Haj-Ahmad. Genomic Profiling of Hepatitis B Virus and Hepatitis C Virus from 1ml of Urine. ASM 107th General Meeting (Metro Toronto Convention Centre, from May 21 through May 25, 2007 in Toronto, ON, Canada).
  • Y. Haj-Ahmad, M. Abdalla. Urine Proteomic Pattern Analysis for early Hepatitis and Hepatitis-related liver cancer detection. ASM 107th General Meeting (Metro Toronto Convention Centre, from May 21 through May 25, 2007 in Toronto, ON, Canada).
  • M. Abdalla, S. Geng, B. Lam and Y. Haj-Ahmad. Efficient Preservation and Purification of Urinary Proteins. The American Society for Cell Biology (ASCB), 47th Annual Meeting. December 1-5, 2007, Washington D.C, USA.
  • M. Abdalla, S. Geng, B. Lam and Y. Haj-Ahmad. Concurrent RNA-DNA-protein Isolation from Bodily Fluids Using Silicon Carbide. The American Society for Cell Biology (ASCB), 47th Annual Meeting. December 1-5, 2007, Washington D.C, USA.
  • M. Abdalla and Y. Haj-Ahmad. The Urinary Genomic and Proteomic Profiling of Hepatocellular Carcinoma patients Infected with Hepatitis C Virus. American Society for Microbiology, 108th General Meeting. June 1-5, 2008, Boston, MA, USA.
  • The Biology of RNA Silencing. April 25-30, 2009, Victoria, Canada.
  • Alex Haj-Ahmad, Moemen Abdalla and Yousef Haj-Ahmad. Proteomic Profiling of Prostate Cancer and Benign Prostatic Hyperplasia from Urine. HUPO 8th Annual World Congress. September 26-30, 2009, Toronto, ON, Canada.
  • Moemen Abdalla, Bernard Lam, Nezar Rghei and Y. Haj-Ahmad. Effect of RNA Isolation Methods on microRNA Quantity and Quality in plasma. Seventh Annual microRNA in Human Disease and Development. March 28-30, 2011, Cambridge, MA, USA.
  • Abdalla M. A. K and Haj-Ahmad, Y. (2012). Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients. J. Cancer 3, 19-31.
  • Simkin, M., Abdalla, M., El-Mogy, M. and Haj-Ahmad Y. (2012). Differences in the quantity of DNA found in the urine and saliva of smokers versus nonsmokers: implications for the timing of epigenetic events. Epigenomics 4(3), 343-352.
  • Abdalla M. A. K and Haj-Ahmad, Y. (2012). Promising Urinary Protein Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients. J. Cancer 3, 390-403.
  • Zamakhshari, H., Abdalla M. A. K. and Haj-Ahmad. Early Detection of Lung Cancer using microRNA. (Presented in Tri Conference, Feb 2012)
  • Lam, B., Haj-Ahmad, T., Misic, V., Abdalla, M., El-Mogy, M., Kim, W., Rghei, N. and Haj-Ahmad, Y. (2013). Effect of microRNA Content on RNA Purification Efficiency from Biological and Clinical Specimens using Various Isolation Procedures. Molecular Medicine Tri-Conference, February 11-15, San Francisco, CA, USA.
  • Lam, B., Haj-Ahmad, T., Misic, V., Abdalla, M., El-Mogy, M., Kim, W., Rghei, N. and Haj-Ahmad, Y. (2013). Variation Between the Purification Efficiency of microRNA with Different GC Content in Biological and Clinical Specimens. microRNA - Targets and Tools for Therapeutic Development, March 4-5, Cambridge, MA, USA.
  • Abdalla, MA., Haj- Ahmad, T. and Haj-Ahmad, Y. (2013). Comparative Study on the Isolation of Exosomal RNA from Urine Using Different Methods. microRNA - Targets and Tools for Therapeutic Development, March 4-5, Cambridge, MA, USA.
  • Abdalla, MA., Haj- Ahmad, T., Kim, W., Simkin, M., and Haj-Ahmad, Y. (2013). Comparative Study on the Isolation of Exosomal RNA from Plasma Using Different Methods. microRNA - Targets and Tools for Therapeutic Development, March 4-5, Cambridge, MA, USA.
  • Mohamed El-Mogy, Moemen Abdalla, Shereen N. Mahmoud, Taha Alex Haj-Ahmad, Yousef Haj-Ahmad. Non-invasive, Rapid Detection of Human Hepatitis B Virus from Saliva Samples. Next Generation Dx Summit (Washington, DC). August 20-22, 2013
  • Moemen AK Abdalla, Mohamed El-Mogy, Robert DiPietro, Taha Alex Haj-Ahmad, Yousef Haj-Ahmad. An Efficient Method for Concentrating Chlamydia trachomatis from Urine Using Silicon Carbide in Resource Limited Areas. Next Generation Dx Summit (Washington, DC). August 20-22, 2013
  • Moemen Abdalla, Taha Haj- Ahmad and Yousef Haj-Ahmad. Comparative Study on the Isolation of Exosomal RNA from Urine Using Different Methods. Exosome and Circulating Biomarkers (San Diego, CA). September 12-13, 2013.
  • Bernard Lam, Moemen Abdalla, Nezar Rghei and Yousef Haj-Ahmad. Isolation of High Quality RNA with Complete Size Diversity from a Single Mammalian Cell. Exosome and Circulating Biomarkers (San Diego, CA). September 12-13, 2013.
  • Taha Haj-Ahmad, Lila Haj-Ahmad, Mohamed El-Mogy, Moemen Abdalla, Won-Sik Kim, Bernard Lam, Nezar Rghei, Yousef Haj-Ahmad. Sensitivity of DNA Extraction Methods from Different Bodily Fluid for Human Identification. (ISHI) International Symposium on Human Identification (Atlanta, Georgia) October 7-10, 2013
  • Moemen AK Abdalla, Mohamed El-Mogy, Catarina Moreira, Robert DiPietro, Taha Alex Haj-Ahmad, Yousef Haj-Ahmad. The effect of Long-Term Frozen Storage of Urine Samples on the detection of Chlamydia trachomatis in comparison to Preserved - Room temperature Urine Samples. (ASHG) American Society of Human Genetics (Boston MA) October 22-26, 2013.
  • Moemen AK Abdalla, Mohamed El-Mogy, Laura Graziano, Taha Alex Haj-Ahmad, Yousef Haj-Ahmad. Efficient Preservation and Purification of Blood Genomic DNA at Ambient Temperature. American Society for Cell Biology, New orleans, Louisiana; 12/2013.
  • Haj-Ahmad TA, Abdalla MA, Haj-Ahmad Y. (2014). Potential Urinary miRNA Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients. J. Cancer 5(3), 182-191.
  • Haj-Ahmad TA, Abdalla MA, Haj-Ahmad Y. (2014). Potential Urinary Protein Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients. J. Cancer 5(2), 103-114.
  • Moemen AK Abdalla, Vanja Misic, Laura Graziano, Bernard Lam, Yousef Haj-Ahmad. Complete Next-Generation Gene Expression Workflow for microRNAs from Bodily Fluids, Extracellular Vesicles and Small Sample Input - Sample Preservation, RNA Extraction, Amplification and Detection. Molecular Med TriCon 2015, San Francisco; 02/2015.
  • Moemen AK Abdalla, Taha Alex Haj-Ahmad, Yousef Haj-Ahmad. Urinary miR-1825 and miR-484: An Oncogene and a Tumor- Suppressor Gene among Prostate Cancer patients. American Association for Cancer Research Annual Meeting 2015, Philadelphia, Pennsylvania; 04/2015.
  • Basma M Abbas, Moemen AK Abdalla, Mohammed El-Mogy, Yousef Haj-Ahmad. Oncolytic adenovirus Ad5dlE1b replication efficiency is dependent on p53 mutation type in cancer cells. American Association for Cancer Research Annual Meeting 2015, Philadelphia, Pennsylvania; 04/2015.
  • Attending AACR Annual Meeting 2016 (American Association for Cancer Research), April 16 - 20, Ernest N. Morial Convention Center, New Orleans, Louisiana
  • Attending AAI Annual Meeting (Immunology 2016), May 13 - 17, Washington State Convention Center, Seattle, Washington
  • Mohamed A. El-Mogy, Moemen A.K. Abdalla, Vanja Misic, Yousef Haj-Ahmad, Effect of adenovirus infection on transgene expression under the adenoviral MLP/TPL and the CMVie promoter/enhancer in CHO cells, In Journal of Genetic Engineering and Biotechnology, Volume 15, Issue 1, 2017, Pages 211-217, ISSN 1687-157X
  • Moemen Abdalla, Taha Haj- Ahmad, Adnan Igdoura and Yousef Haj-Ahmad. Assessing the Effect of Simulated Shipping on Cell-Free DNA in Blood Collected in Norgen, Streck and EDTA Tubes. Next Generation Dx Summit (Washington, DC). August 15-17, 2017
  • Moemen Abdalla, Taha Haj- Ahmad, Adnan Igdoura and Yousef Haj-Ahmad. Norgen’s cf-DNA Preservative Tube Preserves & Prevents the Contamination of Circulating Cell-Free DNA by Cellular Genomic DNA during Shipping as compared to other cf-DNA Preservative Tubes. Next Generation Dx Summit (Washington, DC). August 15-17, 2017.
  • Jackson, L., et al. "Development and Analytic Validation of an Automated Circulating RNA Extraction System Using a Laboratory Validated ddPCR Test Process." JOURNAL OF MOLECULAR DIAGNOSTICS. Vol. 19. No. 6. 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA: ELSEVIER SCIENCE INC, 2017.
  • Armstrong, David A., et al. "Pre-analytical handling conditions and small RNA recovery from urine for miRNA profiling." The Journal of Molecular Diagnostics 20.5 (2018): 565-571.
  • Armstrong, David A., et al. "Extracellular vesicles from Pseudomonas aeruginosa suppress MHC-related molecules in human lung macrophages." Immunohorizons 4.8 (2020): 508-519.

Timeline

Clinical Laboratory Director

Norgen Biotek Corp
06.2020 - 08.2023

Director of Sales and Marketing

Norgen Biotek Corp
09.2019 - 08.2023

Senior Lead Research Scientist

Norgen Biotek Corp
01.2010 - 08.2023

Postdoctoral Research Scientist

Norgen Biotek Corp
01.2009 - 12.2009

Doctor of Philosophy (Ph.D.) in Biotechnology -

Brock University

Master of Science in Biochemistry -

Alexandria University

Bachelor of Science in Biochemistry -

Alexandria University
Moemen Abdalla